Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers

Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers

Objective Analyze the demographics, clinical characteristics, efficacy and safety of natalizumab treatment in Brazilian patients with multiple sclerosis (MS) followed up for at least 12 months, in two tertiary MS care centers in São Paulo.Method We evaluated the effect of natalizumab treatment on an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Enedina Maria Lobato de Oliveira, Renata Faria Simm, Gorana Dasic, Marília Mamprim de Morais, Samira Luiza dos Apostolos Perreira, Dagoberto Callegaro
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2015-09-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	natalizumabe esclerose múltipla progressão da incapacidade taxa de surto
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900736&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients
by: Luiz Henrique da Silva Nali, et al.
Published: (2014-12-01)

Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2016-08-01)

Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive
by: Yara Dadalti Fragoso, et al.
Published: (2013-10-01)

Increased multiple sclerosis relapses related to lower prevalence of pain
by: José Vinícius Martins da Silva, et al.
Published: (2015-07-01)

Aumento dos receptores solúveis da interleucina-2 na esclerose múltipla: estudo preliminar em 26 pacientes
by: Charles P. Tilbery, et al.
Published: (1994-06-01)

by: Yára Dadalti Fragoso, et al.
Published: (2013-03-01)

Depressão na esclerose multipla forma remitente-recorrente
by: Maria Fernanda Mendes, et al.
Published: (2003-09-01)

by: Yára Dadalti Fragoso, et al.
Published: (2013-03-01)

Multiple sclerosis risk perception and acceptance for Brazilian patients
by: Denis Bernardi Bichuetti, et al.

The effect of social support on the quality of life of patients with multiple sclerosis
by: David Castro Costa, et al.
Published: (2012-02-01)

Coping strategies and mood profiles in patients with multiple sclerosis
by: Aysel Milanlioglu, et al.
Published: (2014-07-01)

Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
by: Caroline Vieira Spessotto, et al.
Published: (2016-08-01)

Esclerose múltipla: estudo de pacientes com a forma surto-remissão cadastrados na Secretaria de Estado da Saúde de Minas Gerais Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary State for Health
by: Eustáquio Claret dos Santos, et al.
Published: (2007-09-01)

Recrudescence of Natalizumab‐Induced Pneumonitis and Peripheral Hypereosinophilia: Case Report and Literature Review
by: Gerardo Arwi, et al.
Published: (2025-04-01)

Esclerose múltipla: estudo clínico de 50 pacientes acompanhados no Ambulatório de Neurologia UNIFESP-EPM
by: OLIVEIRA ENEDINA MARIA LOBATO DE, et al.
Published: (1999-01-01)

The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis
by: Denis Bernardi Bichuetti, et al.
Published: (2015-04-01)

Ressonância magnética na esclerose múltipla: análise de 270 casos
by: Guilberto Minguetti
Published: (2001-09-01)

Influence of treatment in multiple sclerosis dysability: an open, retrospective, non-randomized long-term analysis Influência do tratamento na incapacidade da esclerose múltipla: estudo aberto, retrospectivo e não randomizado em longo prazo
by: Lineu Cesar Werneck, et al.
Published: (2010-08-01)

Why this is not multiple sclerosis: a case based approach
by: Zaira Fernanda Martinho Nicolau, et al.
Published: (2015-01-01)

Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis
by: Guilherme Sciascia do Olival, et al.
Published: (2013-08-01)

Teste de destreza manual da caixa e blocos em indivíduos normais e em pacientes com esclerose múltipla
by: Maria Fernanda Mendes, et al.
Published: (2001-12-01)

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy
by: Prosperini L, et al.
Published: (2025-04-01)

A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis
by: Bruna Antinori Vignola da Fonseca, et al.
Published: (2016-02-01)

Optical coherence tomography evaluation of retinal nerve fiber layer in longitudinally extensive transverse myelitis
by: Frederico C. Moura, et al.
Published: (2011-02-01)

Validation of the brazilian version of Guy's neurological disability scale Validação da versão brasileira da escala de incapacidade neurológica de Guy
by: Carolina R. Araujo, et al.
Published: (2007-09-01)

The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2014-09-01)

Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: III. Diretrizes baseadas em evidências e recomendações
by: Lana-Peixoto Marco Aurélio, et al.
Published: (2002-01-01)

The effect of functional limitations and fatigue on the quality of life in people with multiple sclerosis O efeito das limitações funcionais e da fadiga na qualidade de vida de indivíduos com esclerose múltipla
by: Leandro Alberto Calazans Nogueira, et al.
Published: (2009-09-01)

Impacts of environmental tobacco smoke on the onset and progression of multiple sclerosis: a systematic review
by: Marco Antônio Machado Schlindwein, et al.
Published: (2024-03-01)

Patients with multiple sclerosis present low levels of empathy
by: Marcos Barbosa de Almeida, et al.

Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
by: Maria Celica Ysrraelit, et al.
Published: (2021-06-01)

Natalizumab-associated progressive multifocal leukoencephalopathy
by: Trevor Glenn, et al.
Published: (2025-06-01)

No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South
by: Yara Dadalti Fragoso, et al.

Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease
by: Denis Bernardi Bichuetti, et al.
Published: (2013-05-01)

Esclerose múltipla, ependimoma medular e meningioma intracraniano: relato de caso
by: MÔNICA F. COSTA, et al.
Published: (2000-12-01)

Guideline for multiple sclerosis treatment in Brazil: Consensus from the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology
by: Elizabeth Regina Comini-Frota, et al.

Nomeação e fluência verbal em portadores de Esclerose Múltipla = Naming and verbal fluency in patients with Multiple Sclerosis
by: Guaresi, Ronei
Published: (2013-01-01)

Clinical and epidemiological profile of patients with multiple sclerosis in Uberaba, Minas Gerais, Brazil
by: Sônia Beatriz Félix Ribeiro, et al.
Published: (2011-04-01)

Benign multiple sclerosis: aspects of cognition and neuroimaging
by: Alyne Mendonça Marques Ton, et al.

Prevalence of multiple sclerosis in Goiânia, Goiás, Brazil
by: Taysa Alexandrino Gonsalves Jubé Ribeiro, et al.